The effect of calcium sodium phosphosilicate on dentin hypersensitivity: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Zhu, Mengjiao ^a   Li, Jialing ^a   Chen, Bin ^a   Mei, Li ^b   Yao, Liang ^c   Tian, Jinhui ^c   Li, Huang ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SODIUM PHOSPHOSILICATE; DENTAL MATERIAL; PLACEBO; TOOTHPASTE; UNCLASSIFIED DRUG; DESENSITIZING AGENT; GLASS; NOVAMIN;

ARTICLE; DENTIN SENSITIVITY; ELECTROSTIMULATION; EVAPORATION; HUMAN; META ANALYSIS; PREVENTIVE DENTISTRY; STIMULUS RESPONSE; SYSTEMATIC REVIEW; TACTILE STIMULATION; THERAPY EFFECT; THERMAL STIMULATION; TOOTH PAIN; TREATMENT OUTCOME;

DENTIN DESENSITIZING AGENTS; DENTIN SENSITIVITY; GLASS; HUMANS; TOOTHPASTES;

EID: 84952645328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140176     Document Type: Article

References (55)

1. Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R. Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin Periodontol. 1997; 24: 808-813. PMID: 9402502
2. Que K, Ruan J, Fan X, Liang X, Hu D. A multi-centre and cross-sectional study of dentine hypersensitivity in China. J Clin Periodontol. 2010; 37: 631-637. doi: 10.1111/j.1600-051X.2009.01513.x PMID: 20041975
3. Scaramucci T, de Almeida Anfe TE, da Silva Ferreira S, Frias AC, Sobral MAP. Investigation of the prevalence, clinical features, and risk factors of dentin hypersensitivity in a selected Brazilian population. Clin Oral Investig. 2014; 18: 651-657. doi: 10.1007/s00784-013-1008-1 PMID: 23740320
4. Splieth CH, Tachou A. Epidemiology of dentin hypersensitivity. Clin Oral Investig. 2013; 17: S3-S8. doi: 10.1007/s00784-012-0889-8 PMID: 23224064
5. Brännström M, Lindén LÅ, Åström A. The hydrodynamics of the dental tubule and of pulp fluid. A discussion of its significance in relation to dentinal sensitivity. Caries Res. 1967; 1: 310-317. PMID: 5241870
6. Brännström M, Aström A. The hydrodynamics of the dentine; its possible relationship to dentinal pain. Int Dent J. 1972; 22: 219-227. PMID: 4505631
7. Sykes LM. Dentine hypersensitivity: a review of its aetiology, pathogenesis and management. SADJ. 2007; 62: 66-71.
8. Martens LC. A decision tree for the management of exposed cervical dentin (ECD) and dentin hypersensitivity (DHS). Clin Oral Investig. 2013; 17: S77-S83. doi: 10.1007/s00784-012-0898-7 PMID: 23262746
9. Nagata T, Ishida H, Shinohara H, Nishikawa S, Kasahara S, Wakano Y, et al. Clinical evaluation of a potassium nitrate dentifrice for the treatment of dentinal hypersensitivity. J Clin Periodontol. 1994; 21: 217-221. PMID: 8157777
10. Schiff T, Dotson M, Cohen S, De Vizio W, McCool J, Volpe A. Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: a twelve-week clinical study. J Clin Dent. 1994; 5(Spec No): 87-92. PMID: 8534380
11. Karim BFA, Gillam DG. The efficacy of strontium and potassium toothpastes in treating dentine hypersensitivity: a systematic review. Int J Dent. 2013; 2013: 573258. doi: 10.1155/2013/573258 PMID: 23653647; PubMed Central PMCID: PMC3638644.
12. Poulsen S, Errboe M, Lescay Mevil Y, Glenny AM. Potassium containing toothpastes for dentine hypersensitivity. Cochrane Database Syst Rev. 2006; 3: CD001476. PMID: 16855970
13. Schmidlin PR, Sahrmann P. Current management of dentin hypersensitivity. Clin Oral Investig. 2013; 17: S55-S59. doi: 10.1007/s00784-012-0912-0 PMID: 23274415
14. Pradeep A, Sharma A. Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: a randomized clinical trial. J Periodontol. 2010; 81: 1167-1173. doi: 10.1902/jop.2010.100056 PMID: 20370417
15. Andersson OH, Kangasniemi I. Calcium phosphate formation at the surface of bioactive glass in vitro. J Biomed Mater Res. 1991; 25: 1019-1030. PMID: 1918106
16. Litkowski LJ, Hack GD, Sheaffer HB, Greenspan DC. Occlusion of dentin tubules by 45S5 Bioglass (R). Bioceramics. 1997; 10: 411-414.
17. Burwell A, Jennings D, Muscle D, Greenspan DC. NovaMin and dentin hypersensitivity-in vitro evidence of efficacy. J Clin Dent. 2010; 21: 66-71. PMID: 21207916
18. Wang Z, Sa Y, Sauro S, Chen H, Xing W, Ma X, et al. Effect of desensitising toothpastes on dentinal tubule occlusion: a dentine permeability measurement and SEM in vitro study. J Dent. 2010; 38: 400-410. doi: 10.1016/j.jdent.2010.01.007 PMID: 20097250
19. Milleman JL, Milleman KR, Clark CE, Mongiello KA, Simonton TC, Proskin HM. NUPRO sensodyne prophylaxis paste with NovaMin for the treatment of dentin hypersensitivity: a 4-week clinical study. Am J Dent. 2012; 25: 262-268. PMID: 23243973
20. Pradeep A, Agarwal E, Naik S, Bajaj P, Kalra N. Comparison of efficacy of three commercially available dentifrices [corrected] on dentinal hypersensitivity: a randomized clinical trial. Aust Dent J. 2012; 57: 429-434. doi: 10.1111/j.1834-7819.2012.01726.x PMID: 23186566
21. Greenspan DC. NovaMin and tooth sensitivity-an overview. J Clin Dent. 2010; 21: 61-65. PMID: 21207915
22. Talioti E, Hill R, Gillam DG. The efficacy of selected desensitizing OTC products: a systematic review. ISRN Dent. 2014; 2014: 865761. doi: 10.1155/2014/865761 PMID: 25006466; PubMed Central PMCID: PMC4005032.
23. Bae JH, Kim YK, Myung SK. Desensitizing toothpaste versus placebo for dentin hypersensitivity: a systematic review and meta-analysis. J Clin Periodontol. 2015; 42: 131-141. doi: 10.1111/jcpe.12347 PMID: 25483802
24. West NX, Seong J, Davies M. Management of dentine hypersensitivity: efficacy of professionally and self-administered agents. J Clin Periodontol. 2015; 42: S256-S302. doi: 10.1111/jcpe.12336 PMID: 25495777
25. Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med. 2004; 19: 51-56. PMID: 14748860
26. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med. 2002; 21: 1539-1558.
27. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004; 328: 1490. PMID: 15205295
28. GlaxoSmithKline. Dose response of a tubule occlusion agent. ClinicalTrials.gov; 2013. [cited 2015 Jan 14] Available: https://www.clinicaltrials.gov/ct2/show/NCT01075256?term=DoseResponseofaTubuleOcclusionAgent&rank=1.
29. GlaxoSmithKline. Exploratory study to evaluate an occlusion based dentifrice in relief of dentinal hypersensitivity. ClinicalTrials.gov; 2014. [cited 2015 Jan 14] Available: https://www.clinicaltrials.gov/ct2/show/NCT01691560?term=ExploratoryStudytoEvaluatetheEfficacyofanOcclusionBasedDentifriceinReliefofDentinalHypersensitivity&rank=2.
30. Du Min Q, Bian Z, Jiang H, Greenspan DC, Burwell AK, Zhong J, et al. Clinical evaluation of a dentifrice containing calcium sodium phosphosilicate (novamin) for the treatment of dentin hypersensitivity. Am J Dent. 2008; 21: 210-214. PMID: 18795515
31. Li C, Huang J, Liang H. Toothpaste containing NovaMin is applied to treat dentine hypersensitivity. Chinese Journal Tissue Engineering Research. 2013; 17: 6846-6852.
32. Litkowski L, Greenspan DC. A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity-proof of principle. J Clin Dent. 2010; 21: 77-81. PMID: 21207918
33. Neuhaus KW, Milleman JL, Milleman KR, Mongiello KA, Simonton TC, Clark CE, et al. Effectiveness of a calcium sodium phosphosilicate containing prophylaxis paste in reducing dentine hypersensitivity immediately and 4 weeks after a single application: a double-blind randomized controlled trial. J Clin Periodontol. 2013; 40: 349-357. doi: 10.1111/jcpe.12057 PMID: 23414245
34. Salian S, Thakur S, Kulkarni S, LaTorre G. A randomized controlled clinical study evaluating the efficacy of two desensitizing dentifrices. J Clin Dent. 2010; 21: 82-87. PMID: 21207919
35. Yu Xq, An Yb, Luan Qx. Effects of bio-glass in subgingival scaling and root planing. Beijing Da Xue Bao. 2011; 43: 40-43.
36. Bero L. Industry sponsorship and research outcome: a cochrane review. JAMA Intern Med. 2013; 173: 580-581. doi: 10.1001/jamainternmed.2013.4190 PMID: 23440226
37. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003; 326: 1167-1170. PMID: 12775614
38. Sismondo S. Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemp Clin Trials. 2008; 29: 109-113. PMID: 17919992
39. Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA. 1999; 282: 1453-1457. PMID: 10535436
40. Safer DJ. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis. 2002; 190: 583-592. PMID: 12357091
41. Fischer C, Wennberg A, Fischer RG, Attström R. Clinical evaluation of pulp and dentine sensitivity after supragingival and subgingival scaling. Endod Dent Traumatol. 1991; 7: 259-265. PMID: 1820859
42. von Troil B, Needleman I, Sanz M. A systematic review of the prevalence of root sensitivity following periodontal therapy. J Clin Periodontol. 2002; 29(S3): 173-177.
43. West NX, Lussi A, Seong J, Hellwig E. Dentin hypersensitivity: pain mechanisms and aetiology of exposed cervical dentin. Clin Oral Investig. 2013; 17: S9-S19. doi: 10.1007/s00784-012-0887-x PMID: 23224116
44. Mantzourani M, Sharma D. Dentine sensitivity: past, present and future. J Dent. 2013; 41: S3-17. doi: 10.1016/S0300-5712(13)70002-2 PMID: 23929643
45. Orchardson R, Gillam DG. Managing dentin hypersensitivity. J Am Dent Assoc. 2006; 137: 990-998. PMID: 16803826
46. Kanouse MC, Ash MM Jr. The effectiveness of a sodium monofluorophosphate dentifrice on dental hypersensitivity. J Periodontol. 1969; 40: 38-40. PMID: 4886435
47. Morris MF, Davis RD, Richardson BW. Clinical efficacy of two dentin desensitizing agents. Am J Dent. 1999; 12: 72-76. PMID: 10477986
48. Petersson LG. The role of fluoride in the preventive management of dentin hypersensitivity and root caries. Clin Oral Investig. 2013; 17: S63-S71. doi: 10.1007/s00784-012-0916-9 PMID: 23271217
49. Kim S. Hypersensitive teeth: desensitization of pulpal sensory nerves. J Endod. 1986; 12: 482-485. PMID: 3465853
50. Sharma N, Roy S, Kakar A, Greenspan DC, Scott R. A clinical study comparing oral formulations containing 7.5% calcium sodium phosphosilicate (NovaMin), 5% potassium nitrate, and 0.4% stannous fluoride for the management of dentin hypersensitivity. J Clin Dent. 2010; 21: 88-92. PMID: 21207920
51. Schiff T, Bonta Y, Proskin HM, DeVizio W, Petrone M, Volpe AR. Desensitizing efficacy of a new dentifrice containing 5.0% potassium nitrate and 0.454% stannous fluoride. Am J Dent. 2000; 13: 111-115. PMID: 11763944
52. Peacock JM, Orchardson R. Effects of potassium ions on action potential conduction in A-and C-fibers of rat spinal nerves. J Dent Res. 1995; 74: 634-641. PMID: 7722060
53. Bahreini M, Jalili M, Moradi-Lakeh M. A comparison of three self-report pain scales in adults with acute pain. J Emerg Med. 2015; 48: 10-18. doi: 10.1016/j.jemermed.2014.07.039 PMID: 25271179
54. Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manag. 2011; 41: 1073-1093.
55. Tai BJ, Bian Z, Jiang H, Greenspan DC, Zhong J, Clark AE, et al. Anti-gingivitis effect of a dentifrice containing bioactive glass (NovaMin) particulate. J Clin Periodontol. 2006; 33: 86-91. PMID: 16441730